Back to results

The Inaugural Irish Research Radiation Oncology Group (IRROG) National Conference 2023

The Irish Research Radiation Oncology Group (IRROG) is a newly established collaborative group which aims to unite the five HSE radiotherapy centres under a common research function.
IRROG was initiated in January 2022 from a Health Research Board grant and co-investment from a number of collaborators.
IRROG comprises of:
Cork University Hospital Radiotherapy Department
Galway University Hospital Radiotherapy Department
St Luke’s Radiation Oncology Network (SLRON) at St. Luke’s Hospital, Rathgar
SLRON @St James Hospital
SLRON @Beaumont Hospital
IRROG is undertaking a number of activities in order to elevate Radiation Oncology Research in Ireland and ultimately position Ireland as an international leader in Radiation Oncology Research and Clinical Trials. Through IRROG, a co-ordinated strategic infrastructure is being established with the aim of ensuring uniform standards of excellence in clinical trials and creating a national portfolio of radiotherapy clinical trials. IRROG brings together a critical group of skilled multidisciplinary personnel with significant experience in clinical research and complex radiotherapy.
IRROG activities include national and international radiotherapy trials; investigating new technologies and combinations of drug therapy with radiotherapy; quality assurance, education and training; and co-ordination with national and public-patient groups to ensure that relevant important trials are performed for the benefit of Irish patients.
IRROG’s vision is to improve cancer outcomes by providing all patients in Ireland with equal access to a portfolio of high-quality radiotherapy clinical trials. IRROG’s Msion is to build and support a national radiotherapy trials group and streamline work practices to ensure safe delivery of novel radiotherapy interventions through excellent research.
Through the “Irish Research Radiation Oncology Group National Conference”, IRROG will collaborate and interact with key players in the Irish cancer research community in order to provide support, disseminate ideas and to ultimately enhance the research environment and experience for Irish cancer patients.